Benzo[a]pyrene (BaP)

CASRN 50-32-8

On this page:

Health Effects Assessment for Benzo[a]pyrene

Notice - This site contains archived material(s).

Archive disclaimer
Archived files are provided for reference purposes only. The file was current when produced, but is no longer maintained and may now be outdated. Persons with disabilities having difficulty accessing archived files may contact the NCEA Webmaster for assistance. Please use the contact form if you need additional assistance.


This final report represents a brief, quantitatively oriented scientific summary of health effects data. It was developed by the Environmental Criteria and Assessment Office to assist the Office of Emergency and Remedial Response in establishing chemical-specific health-related goals of remedial actions. If applicable, chemical-specific subchronic and chronic toxicity interim acceptable intakes are determined for systemic toxicants, or q(sub 1)* values are determined for carcinogens for both oral and inhalation routes. A q(sub 1)* was determined for benzo(a)pyrene based on both oral and inhalation exposure.


U.S. EPA. Health Effects Assessment for Benzo[a]pyrene. U.S. Environmental Protection Agency, Washington, D.C., EPA/540/1-86/022 (NTIS PB86134335), 1984.

Top of Page